Chinese Traditional and Herbal Drugs
|
2025, 56(8): 2995-3004
Research progress on the prevention and treatment of renal interstitial fibrosis by traditional Chinese medicines based on the activation of myofibroblasts and signaling pathways
Full
LI Hesheng1, LI Chunchan1, GUO Huahui1, HUANG Jiacheng1, LAN Congying1, CHEN Penghui1, DING Tingting1, YANG Yilong1, HUANG Renfa1
Affiliations
1 Shenzhen Hospital, Guangzhou University of Chinese Medicine (Futian), Shenzhen 518034, China
doi: 10.7501/j.issn.0253-2670.2025.08.032
Outline
Renal interstitial fibrosis (RIF) represents a pivotal stage in the progression of renal tissue injury to end-stage renal disease, and its severity is directly correlated with clinical prognosis. In the pathology of RIF, myofibroblasts (MyoF) are considered to be the core effector cells that trigger renal structural remodeling and the decline of renal function. Chronic inflammatory responses and abnormal activation of growth factors and fibrogenic cytokines can promote the recruitment and proliferation of MyoF, resulting in excessive extracellular matrix deposition in renal tissue. This article focuses on the multiple origins and activation mechanisms of MyoF in RIF. It investigates the conditions and transformation processes of renal interstitial fibroblasts, pericytes, renal tubular epithelial cells, endothelial cells, and bone marrow-derived cells into MyoF. Moreover, it summarizes the research progress in inhibiting the activation of MyoF and treating RIF using traditional Chinese medicine (TCM) through key pathways, such as the transforming growth factor-β1 (TGF-β1) pathway, platelet-derived growth factor pathway, reactive oxygen species (ROS) pathway, and Hedgehog signaling pathway. By analyzing the specific mechanisms and multi-target advantages of TCM active ingredients and TCM compound prescriptions in preventing and treating RIF, this article aim to provide more scientific evidence for the precise treatment of RIF with TCM.
myofibroblasts
/
renal interstitial fibrosis
/
curcumin
/
ligustrazine
/
oxymatrine
/
Shenkang injection
/
effector cells
/
signaling pathway
李贺生, 李春婵, 郭华慧, 黄家晟, 兰聪颖, 陈鹏辉, 丁婷婷, 杨义龙, 黄仁发.
基于“肌成纤维细胞激活”及其信号通路探讨中药防治肾间质纤维化的研究进展.
中草药,
2025
, 56
(8)
: 2995
-3004
.
DOI: 10.7501/j.issn.0253-2670.2025.08.032
LI Hesheng, LI Chunchan, GUO Huahui, HUANG Jiacheng, LAN Congying, CHEN Penghui, DING Tingting, YANG Yilong, HUANG Renfa.
Research progress on the prevention and treatment of renal interstitial fibrosis by traditional Chinese medicines based on the activation of myofibroblasts and signaling pathways[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(8)
: 2995
-3004
.
DOI: 10.7501/j.issn.0253-2670.2025.08.032
Year 2025 volume 56 Issue 8
51
9
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.08.032
- Receive Date:2024-09-27
- Online Date:2026-11-13